Data
Lookout
Search
Browse
Diseases
Sponsors
Pipeline Pulse
Weekly Report
Watchlist
Blog
Pricing
Sign In
Home
NCT07378579
Clinical Trial
An Investigational Study to Evaluate the Cardiac Safety Assessment (TQTc Study) of ESK-001
Completed
Phase 1
View on ClinicalTrials.gov →
Summary
This a phase 1, partially blinded, randomized, crossover study to determine the pharmacokinetics (PK) and QT/QTc interval of study drug (ESK-001) in healthy volunteer participants,
Trial Details
NCT Number
NCT07378579
Lead Sponsor
Alumis Inc
Conditions
Healthy Volunteer
Enrollment
52 participants
Start Date
2024-06-21
Primary Completion
2024-08-31
(estimated)
Study Completion
2024-08-31
(estimated)
Updated on ClinicalTrials.gov
2026-01-30